Hazardous Effect of Dietary Trans Fats on Human Health and Regulations

인체에 미치는 트랜스지방의 위해와 규제현황

  • Published : 2007.12.31

Abstract

Trans-fatty acids (TFAs) are defined as the sum of all unsaturated fatty acids that contain one or more non-conjugated double bonds in a trans configuration. Dietary trans- fatty acids originate from commercially hydrogenated oils and from dairy and meat fats. From the perspective of the food industry, partially hydrogenated vegetable oils are attractive because of their long shelf life, stability during deep-frying, and semisolidity, which can be customized to enhance the palatability of baked goods and fried foods. Although no definite differences have been documented so far between the metabolic and health effects of industrial and ruminant TFAs, the intake of industrially produced TFA has declined, and in Europe, the majority of TFAs are of ruminant origin. Due to the scientific evidence associating TFA intake with increased risk of coronary heart disease (CDH), the Korea Food and Drug Administration (KFDA) issued a final rule that requires the amount of trans fat present in foods to be declared on the nutrition label, by December 1, 2007. In addition, many food manufacturers who use partially hydrogenated oils in their products have developed, or are considering ways, to reduce or eliminate trans-fatty acids from certain food products.

Keywords

References

  1. Ackman RG, Mag TK. 1998. Trans fatty acids and the potential for less in technical products. In: Sebedio JL, Christie WW, eds. Trans fatty acids in human nutrition. Dundee, UK: The Oily Press. pp 35-58
  2. Ascherio A, Katan MB, Zock PL, Stampfer MJ, Willett WC. 1999. Trans fatty acids and coronary heart disease. N Engl J Med 340(12): 1994-1998 https://doi.org/10.1056/NEJM199906243402511
  3. Bakker N, van't Veer P, Zock PL, the Euramic Study Group. 1997. Adipose fatty acids and cancers of breast, prostate and colon: An ecological study. Int J Cancer 72(4): 587-596 https://doi.org/10.1002/(SICI)1097-0215(19970807)72:4<587::AID-IJC6>3.0.CO;2-M
  4. Craig-Schmidt MC. 2006 World-wide consumption of trans fatty acids. Atherosclerosis Supplements 7(1): 1-4
  5. Daniel DR, Thompson LD, Shriver BJ, Wu C-K, Hoover LC. 2005 Nonhydrogenated cottonseed oil can be used as a deep fat frying medium to reduce trans-fatty acid content in french fries. J Am Dietetic Association 105(12): 1927-1932 https://doi.org/10.1016/j.jada.2005.09.029
  6. Eckel RH, Borra S, Lichtenstein AH, Yin-Piazza SY. 2007. Understanding the complexity of trans fatty acid reduction in the American diet. American Heart Association trans fat conference 2006: Report of the trans fat conference planning group
  7. Emken EA. 1984. Nutrition and biochemistry of trans and positional fatty acid isomers in hydrogenated oils. Annu Rev Nutr 4(2): 339-348 https://doi.org/10.1146/annurev.nu.04.070184.002011
  8. Formo MW. 1979. Fats in the diet. In: Swern D, ed. Bailey's industrial oil and fat products. New York, NY, John Wiley and Sons. pp 233-270
  9. Geibler C, Brede O, Reinhardt J. 2003. cis-trans-Isomerization of unsaturated fatty acids during $\gamma$-irradiation of barley grains. Radiation Physics and Chemistry 67(2): 105-113 https://doi.org/10.1016/S0969-806X(03)00003-3
  10. Ha J, Seo D. 2006. Trans fat in foods. Food Science and Industry 39(2): 18-23
  11. Hu FB, Manson IE, Willet WC. 2001. Types of dietary fat and risk of coronary heart disease. J Am Coli Nutr 20(1): 5-19 https://doi.org/10.1080/07315724.2001.10719008
  12. Hunter JE. 2005. Dietary levels of tram-fatty acids: basis for health concerns and industry efforts to limit use. Nutr Research 25(4): 499-513 https://doi.org/10.1016/j.nutres.2005.04.002
  13. Hunter JE, Ip C, Hollenbach EJ. 1985. Isomeric fatty acids and tumorigenesis: a commentary on recent work. Nutr Cancer 7(10): 1999-2005
  14. Leth T, Bysted A, Erendah-Mikkelsen A. 2005. The effect of the regulation on trans fatty acid content in Danish food. First International Symposium on Trans Fatty Acids and Health, Rungstedgaard, Denmark, September p 11-13
  15. Lichtenstein AH, Ausman LM, Jalbert SM, Schaefer IJ. 1999. Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med 340(10): 1933-1940 https://doi.org/10.1056/NEJM199906243402501
  16. Malmros H, Wigand G. 1957. The effect on serum cholesterol of diets containing different fats. Lancet 273(1): 1-7 https://doi.org/10.1016/S0140-6736(02)98779-9
  17. Mann G. 1994. Metabolic consequence of dietary trans fatty acids. Lancet. 343: 1268-1271 https://doi.org/10.1016/S0140-6736(94)92157-1
  18. Mattson FH, Hollenbach EJ, Klingman AM. 1975. Effect of hydrogenated fat on the plasma cholestrol and triglycerides of man. Am J Clin Nutr 28(6): 726-731 https://doi.org/10.1093/ajcn/28.7.726
  19. Mensink R, Katan M. 1990. Effect of dietary trans fatty acids on high density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 323(4): 439-445 https://doi.org/10.1056/NEJM199008163230703
  20. Mensink RP, Zock PL, Kester AD, Katan MB. 2003. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J elin Nutr 77(9): 1146-1155 https://doi.org/10.1093/ajcn/77.5.1146
  21. Moreno MCMM, Olivares DM, Lopez FJA, Adelantado JVG, Reig FB. 1999. Determination of unsaturation grade and trans isomers generated during thermal oxidation of edible oils and fats by FTIR. J Molecular Structure 482-483(4): 551-556 https://doi.org/10.1016/S0022-2860(98)00937-5
  22. Moss J. 2006. Labeling of trans fatty acid content in food, regulations and limits-The FDA view. Atherosclerosis Supplements 7(1): 57-59
  23. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. 2006. Trans fatty acids and cardiovascular disease. N Engl J Med 354(4): 1601-1613 https://doi.org/10.1056/NEJMra054035
  24. Nelson GJ. 1998. Dietary fat, trans fatty acids and risk of coronary heart disease. Nutr Rev 8(2): 250-252 https://doi.org/10.1111/j.1753-4887.1950.tb02465.x
  25. Petrek JA, Hudgins LC, Ho M, Bajorumas DR, Hirsch J. 1997. Fatty acid composition of adipose tissue and indication of dietary fatty acids and breast cancer prognosis. J. Clin Oncol 15(4): 1377-1380 https://doi.org/10.1200/JCO.1997.15.4.1377
  26. Ren YF, Alam SQ, Alam BS, Keefer IM. 1988. Adenylate cyclase and beta-receptors in salivary glands or rats fed diets containing trans fatty acids. Lipids 23(2): 304-312 https://doi.org/10.1007/BF02537338
  27. Romero A, Cuesta C, Sanchez-Muniz FJ. 2000. Trans fatty acid production in deep fat frying of frozen foods with different oils and frying modalities. Nutrition Research 20(4): 599-608 https://doi.org/10.1016/S0271-5317(00)00150-0
  28. Tarrago-Trani MT, Phillips KM, Lemar LE, Holden, JM. 2006. New and existing oils and fats used in products with reduced trans fatty acid content. J Am Dietetic Association 106(6): 867-880 https://doi.org/10.1016/j.jada.2006.03.010
  29. Turpeinen AM, Mutanen M, Aro A, Salminen I, Basu S, Palmquist DL, Griinari JM. 2002. Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am J Clin Nutr 76(3): 504 - 510 https://doi.org/10.1093/ajcn/76.3.504
  30. Valenzuela A, Morgado N. 1999 Trans fatty acid isomers in human health and in the food industry. Biol Res 32(2): 273-287
  31. Wolff RL, Precht D, Molkentin J. 1998. Occurrence and distribution profiles of trans-18: 1 acids in edible fats of natural origin. In: Sebedio JL, Christie WW, eds. Trans fatty acids in human nutrition. Dundee, UK: The Oily Press. pp 1-33